What Makes Real-World Evidence Credible? Insights from Academic Research
Like many professional conversations today, this one began on LinkedIn. Tasfia Roshnee, a PhD candidate at the College of Engineering at Penn State, reached out to share how she was using TriNetX real-world data (RWD) to study integrated care pathways in chronic...
Strengthening Muscle-Invasive Bladder Cancer Care: The Untapped Potential of Perioperative Systemic Therapy
Bladder cancer remains a major global health challenge, ranking as the tenth most common cancer overall and the sixth among men. Yet across geographies, the burden of disease looks very different, driven by a complex mix of environmental exposures, diagnostic...
How Taichung Veterans General Hospital is Advancing Real-World Evidence Research with TriNetX
We’re pleased to recognize Taichung Veterans General Hospital (TCVGH) as our Q2 2026 Network Spotlight winner! TCVGH has embraced real-world data (RWD) to drive clinical research and deliver evidence-based care. Through their partnership with TriNetX, the...
TriNetX Enhances its Ability to Federate Genomics Data Across its Global Network of Providers through the Acquisition of Key Assets of Zetta Genomics
TriNetX® will continue to support all existing Zetta Genomics customers utilizing the award-winning XetaBase® technology for research and patient care innovation Cambridge, MA and Cambridge, UK — April 7, 2026 — TriNetX, the world’s leading federated health data...
Regeneron Collaborates with TriNetX to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions
Regeneron has exclusive opportunity to connect large-scale genomic and proteomic data cohorts to TriNetX’s industry-leading global network of electronic health record data Collaboration will expand Regeneron’s world-leading genomic and proteomic EHR-linked database ...Accelerating Study Design Decisions with Real‑World Data
Designing a clinical study has never been more complex—or more consequential. As protocols grow increasingly restrictive and timelines tighten, early design decisions can determine whether a study launches smoothly or struggles with amendments, delays, and...
Patient-Centricity at the Point of Care: A Clinician’s Perspective on Rethinking Trials
When I think about the phrase “patient-centricity,” I often pause. It’s everywhere in our industry: clinical trial brochures, conference panels, even corporate mission statements. But too often, it risks becoming a buzzword rather than a lived reality. In our...
TriNetX Named Best of Show Finalist at SCOPE: Advancing Clinical Trial Planning with Conversational AI and Enhanced API Capabilities
TriNetX is proud to announce that we were named a Best of Show Finalist at SCOPE, the summit for clinical ops executives, one of the industry’s premier events focused on advancing clinical operations and innovation. This recognition highlights our continued commitment...